Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Voyager Therapeut (VYGR)
Voyager Therapeut (VYGR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 391,995
  • Shares Outstanding, K 43,995
  • Annual Sales, $ 40,910 K
  • Annual Income, $ -46,410 K
  • 60-Month Beta 0.98
  • Price/Sales 2.34
  • Price/Cash Flow N/A
  • Price/Book 1.92
Trade VYGR with:

Options Overview Details

View History
  • Implied Volatility 87.68% ( +1.89%)
  • Historical Volatility 44.85%
  • IV Percentile 90%
  • IV Rank 42.43%
  • IV High 164.12% on 11/07/23
  • IV Low 31.35% on 11/09/23
  • Put/Call Vol Ratio 0.26
  • Today's Volume 273
  • Volume Avg (30-Day) 95
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 2,891
  • Open Int (30-Day) 3,013

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.59
  • Number of Estimates 4
  • High Estimate -0.51
  • Low Estimate -0.62
  • Prior Year -0.61
  • Growth Rate Est. (year over year) +3.28%

Price Performance

See More
Period Period Low Period High Performance
1-Month
7.08 +25.85%
on 02/13/24
8.94 -0.34%
on 02/27/24
+1.40 (+18.64%)
since 01/26/24
3-Month
6.66 +33.78%
on 11/29/23
11.72 -23.98%
on 01/02/24
+1.99 (+28.76%)
since 11/27/23
52-Week
6.06 +47.03%
on 11/13/23
14.34 -37.87%
on 05/22/23
+1.75 (+24.44%)
since 02/27/23

Most Recent Stories

More News
3 B-Rated Pharma Stocks to Secure Now With Great Value

The pharmaceutical industry, which experienced significant growth over the past years, is anticipated to remain buoyed, driven by the increasing prevalence of chronic diseases, advancements in medical...

PCRX : 29.85 (+0.37%)
SNY : 48.21 (+0.02%)
VYGR : 8.91 (+3.12%)
3 Pharma Gems Driving Profits Now

The pharmaceutical industry is expected to expand rapidly in the coming years, driven by rising global medical needs and tech advancements. Therefore, fundamentally strong pharma stocks Kamada (KMDA),...

KMDA : 6.40 (+4.58%)
OPTN : 1.6900 (+2.42%)
VYGR : 8.91 (+3.12%)
S&P Futures Tick Lower as Key U.S. Jobs Report Looms

March S&P 500 E-Mini futures (ESH24) are trending down -0.23% this morning as investors looked ahead to the crucial monthly U.S. nonfarm payrolls report for further clues on the timing of possible interest-rate...

ESH24 : 5,072.25 (-0.35%)
WBA : 21.63 (+3.05%)
MBLY : 25.36 (+4.02%)
AAPL : 182.63 (+0.81%)
ALL : 159.54 (-0.16%)
EDV.LN : 1,239.000 (-2.98%)
LIGHT.NA : 24.310 (-2.05%)
PTON : 4.70 (+2.84%)
APLT : 5.58 (+5.28%)
IBM : 184.87 (+0.40%)
FUSN : 12.50 (-1.19%)
PLTR : 24.53 (+4.12%)
Are These 3 Pharma Stocks a Buy or Hold Opportunity for December?

The pharmaceutical industry looks well-positioned for long-term growth. So, let us analyze pharma stocks Procaps Group (PROC), Voyager Therapeutics (VYGR) and Organon & Co. (OGN) to identify whether they...

OGN : 18.04 (+2.21%)
PROC : 3.06 (-1.61%)
VYGR : 8.91 (+3.12%)
Voyager Therapeutics: Q3 Earnings Snapshot

Voyager Therapeutics: Q3 Earnings Snapshot

VYGR : 8.91 (+3.12%)
3 Value Pharma Stocks to Keep Watching

The pharma industry’s ability to remain resilient in times of economic uncertainty offers an appealing investment opportunity. Hence, fundamentally sound pharma stocks Catalyst Pharmaceuticals (CPRX),...

CPRX : 14.35 (+1.20%)
MOR : 17.67 (-0.11%)
VYGR : 8.91 (+3.12%)
Voyager Therapeutics: Q2 Earnings Snapshot

Voyager Therapeutics: Q2 Earnings Snapshot

VYGR : 8.91 (+3.12%)
2 Biotech Stocks That Could Make You Richer

These biotech companies are seeing a spike in revenue growth.

VYGR : 8.91 (+3.12%)
ZYME : 12.90 (+4.28%)
3 Quality Medical Stocks to Explore

The medical industry is envisioned to remain afloat and thrive in the foreseeable future, thanks to advanced medical discoveries. Therefore, quality medical stocks Amphastar Pharmaceuticals (AMPH), Ironwood...

AMPH : 55.44 (+0.64%)
IRWD : 15.18 (+1.00%)
LLY : 765.00 (-0.90%)
NVS : 103.15 (-0.10%)
VECT : 16.85 (unch)
VYGR : 8.91 (+3.12%)
Voyager Therapeutics (VYGR) Q1 Earnings and Revenues Surpass Estimates

Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of 1,860% and 51.50%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

VYGR : 8.91 (+3.12%)
HUMA : 4.53 (-0.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Strengthening short term outlook on maintaining the current direction.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Voyager Therapeutics, Inc. is a gene therapy company. It focuses on the development of treatments for patients suffering from severe diseases of the central nervous system. Its pipeline includes VY-AADC01, which is in Phase 1b clinical trials for treatment of Parkinson's disease and preclinical programs...

See More

Key Turning Points

3rd Resistance Point 9.56
2nd Resistance Point 9.25
1st Resistance Point 9.08
Last Price 8.91
1st Support Level 8.60
2nd Support Level 8.29
3rd Support Level 8.12

See More

52-Week High 14.34
Fibonacci 61.8% 11.18
Fibonacci 50% 10.20
Fibonacci 38.2% 9.22
Last Price 8.91
52-Week Low 6.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar